Zebra Capital Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-4,495
| Closed | -$200K | – | 130 |
|
|
2021
Q4 | $200K | Sell |
4,495
-1,657
| -27% | -$73.7K | 0.32% | 120 |
|
|
2021
Q3 | $310K | Sell |
6,152
-1,891
| -24% | -$95.3K | 0.38% | 100 |
|
|
2021
Q2 | $631K | Sell |
8,043
-869
| -10% | -$68.2K | 0.74% | 48 |
|
|
2021
Q1 | $509K | Buy |
+8,912
| New | +$509K | 0.56% | 66 |
|
|
2020
Q3 | – | Sell |
-9,089
| Closed | -$220K | – | 194 |
|
|
2020
Q2 | $220K | Buy |
+9,089
| New | +$220K | 0.32% | 135 |
|